Synthetic antibodies inhibit Bcl-2-associated X protein (BAX) through blockade of the N-terminal activation site

Onyinyechukwu Uchime, Zhou Dai, Nikolaos Biris, David Lee, Sachdev S. Sidhu, Sheng Li, Jonathan R. Lai, Evripidis Gavathiotis

Research output: Contribution to journalArticle

13 Citations (Scopus)

Abstract

The BCL-2 protein family plays a critical role in regulating cellular commitment to mitochondrial apoptosis. Pro-apoptotic Bcl-2-associated X protein (BAX) is an executioner protein of the BCL-2 family that represents the gateway to mitochondrial apoptosis. Following cellular stresses that induce apoptosis, cytosolicBAXis activated and translocates to the mitochondria, where it inserts into the mitochondrial outer membrane to form a toxic pore.HowtheBAXactivation pathway proceeds and how this may be inhibited is not yet completely understood. Here we describe synthetic antibody fragments (Fabs) as structural and biochemical probes to investigate the potential mechanisms of BAX regulation. These synthetic Fabs bind with high affinity to BAX and inhibit its activation by the BH3-only protein tBID (truncated Bcl2 interacting protein) in assays using liposomal membranes. Inhibition of BAX by a representative Fab, 3G11, prevented mitochondrial translocation of BAX and BAX-mediated cytochrome c release. Using NMR and hydrogen-deuterium exchange mass spectrometry, we showed that 3G11 forms a stoichiometric and stable complex without inducing a significant conformational change on monomeric and inactive BAX. We identified that the Fab-binding site on BAX involves residues of helices α1/α6 and the α1 -α2 loop. Therefore, the inhibitory binding surface of 3G11 overlaps with the N-terminal activation site of BAX, suggesting a novel mechanism of BAX inhibition through direct binding to the BAX N-terminal activation site. The synthetic Fabs reported here reveal, as probes, novel mechanistic insights into BAX inhibition and provide a blueprint for developing inhibitors of BAX activation.

Original languageEnglish (US)
Pages (from-to)89-102
Number of pages14
JournalJournal of Biological Chemistry
Volume291
Issue number1
DOIs
StatePublished - Jan 1 2016

Fingerprint

bcl-2-Associated X Protein
Chemical activation
Antibodies
Apoptosis
Proteins
Membranes
Blueprints
Immunoglobulin Fragments
Apoptosis Regulatory Proteins
Mitochondria
Die casting inserts
Deuterium
Poisons
Mitochondrial Membranes
Cytochromes c
Mass spectrometry
Hydrogen
Assays
Mass Spectrometry

ASJC Scopus subject areas

  • Biochemistry
  • Cell Biology
  • Molecular Biology

Cite this

Synthetic antibodies inhibit Bcl-2-associated X protein (BAX) through blockade of the N-terminal activation site. / Uchime, Onyinyechukwu; Dai, Zhou; Biris, Nikolaos; Lee, David; Sidhu, Sachdev S.; Li, Sheng; Lai, Jonathan R.; Gavathiotis, Evripidis.

In: Journal of Biological Chemistry, Vol. 291, No. 1, 01.01.2016, p. 89-102.

Research output: Contribution to journalArticle

Uchime, Onyinyechukwu ; Dai, Zhou ; Biris, Nikolaos ; Lee, David ; Sidhu, Sachdev S. ; Li, Sheng ; Lai, Jonathan R. ; Gavathiotis, Evripidis. / Synthetic antibodies inhibit Bcl-2-associated X protein (BAX) through blockade of the N-terminal activation site. In: Journal of Biological Chemistry. 2016 ; Vol. 291, No. 1. pp. 89-102.
@article{21130a2d12334cf0ad0726426cdd7cb1,
title = "Synthetic antibodies inhibit Bcl-2-associated X protein (BAX) through blockade of the N-terminal activation site",
abstract = "The BCL-2 protein family plays a critical role in regulating cellular commitment to mitochondrial apoptosis. Pro-apoptotic Bcl-2-associated X protein (BAX) is an executioner protein of the BCL-2 family that represents the gateway to mitochondrial apoptosis. Following cellular stresses that induce apoptosis, cytosolicBAXis activated and translocates to the mitochondria, where it inserts into the mitochondrial outer membrane to form a toxic pore.HowtheBAXactivation pathway proceeds and how this may be inhibited is not yet completely understood. Here we describe synthetic antibody fragments (Fabs) as structural and biochemical probes to investigate the potential mechanisms of BAX regulation. These synthetic Fabs bind with high affinity to BAX and inhibit its activation by the BH3-only protein tBID (truncated Bcl2 interacting protein) in assays using liposomal membranes. Inhibition of BAX by a representative Fab, 3G11, prevented mitochondrial translocation of BAX and BAX-mediated cytochrome c release. Using NMR and hydrogen-deuterium exchange mass spectrometry, we showed that 3G11 forms a stoichiometric and stable complex without inducing a significant conformational change on monomeric and inactive BAX. We identified that the Fab-binding site on BAX involves residues of helices α1/α6 and the α1 -α2 loop. Therefore, the inhibitory binding surface of 3G11 overlaps with the N-terminal activation site of BAX, suggesting a novel mechanism of BAX inhibition through direct binding to the BAX N-terminal activation site. The synthetic Fabs reported here reveal, as probes, novel mechanistic insights into BAX inhibition and provide a blueprint for developing inhibitors of BAX activation.",
author = "Onyinyechukwu Uchime and Zhou Dai and Nikolaos Biris and David Lee and Sidhu, {Sachdev S.} and Sheng Li and Lai, {Jonathan R.} and Evripidis Gavathiotis",
year = "2016",
month = "1",
day = "1",
doi = "10.1074/jbc.M115.680918",
language = "English (US)",
volume = "291",
pages = "89--102",
journal = "Journal of Biological Chemistry",
issn = "0021-9258",
publisher = "American Society for Biochemistry and Molecular Biology Inc.",
number = "1",

}

TY - JOUR

T1 - Synthetic antibodies inhibit Bcl-2-associated X protein (BAX) through blockade of the N-terminal activation site

AU - Uchime, Onyinyechukwu

AU - Dai, Zhou

AU - Biris, Nikolaos

AU - Lee, David

AU - Sidhu, Sachdev S.

AU - Li, Sheng

AU - Lai, Jonathan R.

AU - Gavathiotis, Evripidis

PY - 2016/1/1

Y1 - 2016/1/1

N2 - The BCL-2 protein family plays a critical role in regulating cellular commitment to mitochondrial apoptosis. Pro-apoptotic Bcl-2-associated X protein (BAX) is an executioner protein of the BCL-2 family that represents the gateway to mitochondrial apoptosis. Following cellular stresses that induce apoptosis, cytosolicBAXis activated and translocates to the mitochondria, where it inserts into the mitochondrial outer membrane to form a toxic pore.HowtheBAXactivation pathway proceeds and how this may be inhibited is not yet completely understood. Here we describe synthetic antibody fragments (Fabs) as structural and biochemical probes to investigate the potential mechanisms of BAX regulation. These synthetic Fabs bind with high affinity to BAX and inhibit its activation by the BH3-only protein tBID (truncated Bcl2 interacting protein) in assays using liposomal membranes. Inhibition of BAX by a representative Fab, 3G11, prevented mitochondrial translocation of BAX and BAX-mediated cytochrome c release. Using NMR and hydrogen-deuterium exchange mass spectrometry, we showed that 3G11 forms a stoichiometric and stable complex without inducing a significant conformational change on monomeric and inactive BAX. We identified that the Fab-binding site on BAX involves residues of helices α1/α6 and the α1 -α2 loop. Therefore, the inhibitory binding surface of 3G11 overlaps with the N-terminal activation site of BAX, suggesting a novel mechanism of BAX inhibition through direct binding to the BAX N-terminal activation site. The synthetic Fabs reported here reveal, as probes, novel mechanistic insights into BAX inhibition and provide a blueprint for developing inhibitors of BAX activation.

AB - The BCL-2 protein family plays a critical role in regulating cellular commitment to mitochondrial apoptosis. Pro-apoptotic Bcl-2-associated X protein (BAX) is an executioner protein of the BCL-2 family that represents the gateway to mitochondrial apoptosis. Following cellular stresses that induce apoptosis, cytosolicBAXis activated and translocates to the mitochondria, where it inserts into the mitochondrial outer membrane to form a toxic pore.HowtheBAXactivation pathway proceeds and how this may be inhibited is not yet completely understood. Here we describe synthetic antibody fragments (Fabs) as structural and biochemical probes to investigate the potential mechanisms of BAX regulation. These synthetic Fabs bind with high affinity to BAX and inhibit its activation by the BH3-only protein tBID (truncated Bcl2 interacting protein) in assays using liposomal membranes. Inhibition of BAX by a representative Fab, 3G11, prevented mitochondrial translocation of BAX and BAX-mediated cytochrome c release. Using NMR and hydrogen-deuterium exchange mass spectrometry, we showed that 3G11 forms a stoichiometric and stable complex without inducing a significant conformational change on monomeric and inactive BAX. We identified that the Fab-binding site on BAX involves residues of helices α1/α6 and the α1 -α2 loop. Therefore, the inhibitory binding surface of 3G11 overlaps with the N-terminal activation site of BAX, suggesting a novel mechanism of BAX inhibition through direct binding to the BAX N-terminal activation site. The synthetic Fabs reported here reveal, as probes, novel mechanistic insights into BAX inhibition and provide a blueprint for developing inhibitors of BAX activation.

UR - http://www.scopus.com/inward/record.url?scp=84952891730&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84952891730&partnerID=8YFLogxK

U2 - 10.1074/jbc.M115.680918

DO - 10.1074/jbc.M115.680918

M3 - Article

VL - 291

SP - 89

EP - 102

JO - Journal of Biological Chemistry

JF - Journal of Biological Chemistry

SN - 0021-9258

IS - 1

ER -